AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
11 Jun, 2026, 11.48 AM IST
Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
11 Jun, 2026, 07.29 AM IST
Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
10 Jun, 2026, 11.47 PM IST
Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
09 Jun, 2026, 02.57 PM IST
Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
31 May, 2026, 05.00 PM IST
Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
15 May, 2026, 07.43 AM IST
Zydus to buy Assertio for $166.4 millionZydus is acquiring US-based Assertio Holdings for $166.40 million to bolster its specialty oncology presence in the US. The deal, structure...
14 May, 2026, 11.15 AM IST
Zydus Lifesciences acquires US pharma firm Assertio for $166 millionIn a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...
14 May, 2026, 01.22 AM IST
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
10 May, 2026, 08.50 AM IST
Experimental pancreatic cancer drug appears to dramatically improve one year survival ratesA groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...
08 May, 2026, 02.50 PM IST
Top private hospitals may drop out of government health plansPrivate hospitals in India are feeling the pinch as government health schemes yield diminishing returns. This downturn provokes a critical ...
07 May, 2026, 12.45 AM IST
US Stocks: Corcept Therapeutics shares surge 32% as lead drug gets FDA nod for ovarian cancerCorcept Therapeutics shares surged after the FDA approved its drug, Lifyorli, for a tough ovarian cancer. This new therapy, combined with c...
25 Mar, 2026, 10.16 PM IST
Miracle drug kills cancer 20,000x faster, and scientists say it has zero side effectsResearchers have redesigned a common chemotherapy drug into a spherical nucleic acid (SNA), dramatically increasing its potency by 20,000 t...
04 Nov, 2025, 03.27 AM IST
New 3D device may cut side-effects of chemotherapy including hair loss, nausea & heart failureThe device absorbs excess chemotherapy drugs before they spread throughout the body.
12 Jan, 2019, 06.03 PM IST
Implanted ports for improving life of cancer patientsWith the technology of implanted ports aimed at increasing the ease of patients fast developing, such ports are being seen to minimise impa...
14 Jan, 2015, 06.27 PM IST
- Indian woman sentenced to 20 years for healthcare fraud
Meera Sachdeva was sentenced to 20 years in federal prison on charges that she defrauded Medicare by submitting false claims for chemothera...
11 Dec, 2012, 11.35 AM IST
- Dabur gets approval for chemotherapy agent
Dabur Pharma says it has received a final approval from the US Food and Drug Administration for its chemotherapy drug Epirubicin injection.
22 Aug, 2007, 08.20 PM IST